[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: AGRI-SIMPLE-2018Pillar: AGRIP-1-1Opening Date: Deadline: Thu, 12 Apr 2018 17:00:00 (Brussels local time)Modification Date: Mon, 16 Apr 2018Latest
Archives
Alkermes Depression Drug Review Goes Ahead After FDA About-Face
Less than a month after the FDA refused to review Alkermes’ new drug application for the company’s depression drug, the
Anything Could Happen at #BIO2018 Start-up Stadium
Last year Jerry Feitelson was accepted into BIO’s Start-up Stadium at the annual BIO International Convention. Armed with his six-minute
Commense Selects Merrimack Pharma Veteran Edward Stewart for CEO
Microbial therapies developer Commense has appointed Edward “Tad” Stewart to serve as the Boston company’s president and CEO. Stewart was
Zacks Investment Research Upgrades Cellect Biotechnology (NASDAQ:APOP) to Buy
Cellect Biotechnology (NASDAQ:APOP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research
Novan Makes Kelly Martin’s CEO Role Permanent
Kelly Martin has been named permanent CEO of Novan (NASDAQ: NOVN). The Morrisville, NC-based drug developer appointed Martin interim CEO
AFLoNext: final conference at ILA Berlin 2018, 26-27 April – 26 April 2018, Berlin ExpoCenter Airport – Conference room: ALFA
[Source: Research & Innovation] AFLoNext, a five-year collaborative project involving 40 entities from 15 countries, aimed at proving and maturing
Rampage: How Hollywood Sees Gene Editing
Genetic engineering has long been a favorite topic for Hollywood screenwriters to exploit to make box office hits. From Jurassic
Bridge Medicines Hires Renzetti as Chief Scientific Officer
Louis Renzetti has been appointed chief scientific officer of New York-based Bridge Medicines. Renzetti most recently worked as chief research
Research Shows How Inhaler Data Help Patients Breathe, Cities Plan
In 2014, the Robert Wood Johnson Foundation committed to fund a first-of-its-kind study of asthma and air quality in Louisville,